Inventor · disambiguated record
Maria Carmen Valcarce Lopez
Also filed as: VALCARCE LOPEZ MARIA CARMEN
16 granted patents·9 pending applications·112 citations·filing 2011–2025
94Inventor score
Top patents by PatentIndex Score
25 records- 0195US10980861B2Glucokinase activator compositions for the treatment of diabetesVTV THERAPEUTICS LLC·Filed 2020·Granted Apr 20, 2021·4 cites·17 claims
- 0295US10952993B2Therapeutic uses of glucokinase activators in combination with insulin or insulin analogsVTV THERAPEUTICS LLC·Filed 2020·Granted Mar 23, 2021·5 cites·13 claims
- 0393US10456406B2Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limbVTV THERAPEUTICS LLC·Filed 2018·Granted Oct 29, 2019·9 cites·11 claims
- 0493US9968613B2Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limbVTV THERAPEUTICS LLC·Filed 2016·Granted May 15, 2018·12 cites·14 claims
- 0593US9487493B2Use of a PPAR-delta agonist for treating muscle atrophyVTV THERAPEUTICS LLC·Filed 2014·Granted Nov 8, 2016·17 cites·20 claims
- 0692US9359313B2Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activatorMJALLI ADNAN M M·Filed 2011·Granted Jun 7, 2016·16 cites·10 claims
- 0790US11096946B2Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limbVTV THERAPEUTICS LLC·Filed 2019·Granted Aug 24, 2021·2 cites·10 claims
- 0890US10064846B2Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activatorVTV THERAPEUTICS LLC·Filed 2017·Granted Sep 4, 2018·6 cites·16 claims
- 0990US9855251B2Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activatorVTV THERAPEUTICS LLC·Filed 2016·Granted Jan 2, 2018·7 cites·16 claims
- 1089US10363244B2Compositions comprising metformin and a glucokinase activatorVTV THERAPEUTICS LLC·Filed 2018·Granted Jul 30, 2019·5 cites·1 claims
- 1188US10004782B2Glucokinase activator compositions for the treatment of diabetesVTV THERAPEUTICS LLC·Filed 2013·Granted Jun 26, 2018·10 cites·19 claims
- 1287US10588943B2Glucokinase activator compositions for the treatment of diabetesVTV THERAPEUTICS LLC·Filed 2018·Granted Mar 17, 2020·5 cites·12 claims
- 1386US11974989B2Therapeutic uses of glucokinase activators in combination with insulin or insulin analogsVTV THERAPEUTICS LLC·Filed 2021·Granted May 7, 2024·1 cites·13 claims
- 1486US11833136B2Therapeutic uses of glucokinase activators in combination with insulin or insulin analogsVTV THERAPEUTICS LLC·Filed 2021·Granted Dec 5, 2023·1 cites·20 claims
- 1586USRE45183EHeteroaryl-ureas and their use as glucokinase activatorsNOVO NORDISK AS·Filed 2013·Granted Oct 7, 2014·7 cites·52 claims
- 1685US9717710B2Treatment of mild and moderate Alzheimer's diseaseVTV THERAPEUTICS LLC·Filed 2013·Granted Aug 1, 2017·5 cites·22 claims
- 1781US2024245656A1Therapeutic uses of glucokinase activators in combination with insulin or insulin analogsVTV THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 1876US2022072005A1Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type i muscle fibers in an immobilized limbVTV THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 1976US2025325536A1Therapeutic uses of glp1r agonistsVTV THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 2074US2025360139A1Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type i muscle fibers in an immobilized limbVTV THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 2162US2019142803A1Treatment of Mild and Moderate Alzheimer's DiseaseVTV THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 2260US2021023072A1Therapeutic uses of glp1r agonistsVTV THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
- 2357US2017326113A1Treatment of Mild and Moderate Alzheimer's DiseaseVTV THERAPEUTICS LLC·Filed 2017·Application pending·0 cites
- 2454US2021338639A1Methods of treating cognitive impairment or improving cognitive functionVTV THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 2534US2015313908A1Combinations of a GLP1R Agonist and Metformin and Use Thereof for the Treatment of Type 2 Diabetes and Other DisordersVTV THERAPEUTICS LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maria Carmen Valcarce Lopez files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →